Robotic surgery for thoracic cancer using the Medtronic Hugo™ system

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the use of the Medtronic Hugo™ robotic system in performing thoracic surgeries for patients with thoracic cancer. The study focuses on the advantages of robotic-assisted surgery, such as enhanced precision and minimally invasive techniques, which can lead to better patient outcomes. Participants will undergo various thoracic surgical procedures, including mediastinal tumor resections and lung resections, utilizing the advanced capabilities of the robotic system. The study aims to gather data on the effectiveness and safety of this innovative surgical approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age between 18 - 80 years
2. Body mass index \<35 kg/m2
3. Suitable for minimally invasive surgery
4. Willingness to participate as demonstrated by giving informed consent

Exclusion Criteria:

1. Contraindication to general anaesthesia
2. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
3. Untreated active infection
4. Non-correctable coagulopathy
5. Emergency surgery
6. Vulnerable population (e.g. mentally disabled, pregnancy)

Where it's running

• Prince of Wales Hospital
  Hong Kong, Hong Kong Recruiting

Study contacts

• Principal investigator: Calvin Sze Hang Ng — Cuhk
• Study coordinator: Calvin Sze Hang Ng
• Email: calvinng@surgery.cuhk.edu.hk
• Phone: 85235052629

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• LUCINAE Registry: Thoracic Cancers in Pregnancy

  This international registry collects data to see how thoracic cancers, including lung cancer, are managed and what outcomes look like for pregnant people and their babies.

  Recruiting at 4 sites Oncology Institute of Southern Switzerland · Baden and 3 other locations · NCT07699861

• Heart-friendly medicines to protect chest-area cancer patients from radiation damage

  This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07685938

• Sodium thiosulfate to protect hearing during cisplatin therapy in adults with solid tumors

  This study tests Pedmark sodium thiosulfate to see if it reduces hearing loss in adults receiving standard cisplatin chemotherapy.

  Recruiting Phase 1/2 University of Arizona · Tucson, Arizona · NCT07407582

• How past alcohol or drug use affects detection and treatment of non-small cell lung cancer

  This project will talk with adults who have non-small cell lung cancer and a history of alcohol or drug use to see if those histories help or hinder getting detected and treated.

  Recruiting at 2 sites University of Southern California · Los Angeles, California and 1 other locations · NCT07186699

• Personalized PULSAR radiotherapy for advanced small cell lung cancer and brain metastases

  This trial will try personalized PULSAR radiotherapy schedules to see if they are safe and helpful for adults with extensive-stage small cell lung cancer who need thoracic radiation and for adults with 1–5 brain metastases.

  Recruiting Phase 1 University of Texas Southwestern Medical Center · Dallas, Texas · NCT07139990

• Pre-surgery heart and breathing variability to spot risk of complications after major thoracic cancer surgery.

  This project will test whether a quick pre-surgery check of heart and breathing variability can help predict which adults having major thoracic cancer operations are more likely to have postoperative complications.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07016022

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.